Should novel organisms developed using oligonucleotide-mediated mutagenesis be excluded from the EU Regulation

This paper discusses regulatory and safety issues associated with the use of oligonucleotide-mediated mutagenesis and provides scientific arguments for not having organisms developed through this technique fall within the scope of the EU regulation of GMOs.